These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 30244564)
1. Current approaches to the pharmacological treatment of Alzheimer's disease. Tan EC; Hilmer SN; Garcia-Ptacek S; Bell JS Aust J Gen Pract; 2018 Sep; 47(9):586-592. PubMed ID: 30244564 [TBL] [Abstract][Full Text] [Related]
3. Treatment of Alzheimer's disease: current status and new perspectives. Scarpini E; Scheltens P; Feldman H Lancet Neurol; 2003 Sep; 2(9):539-47. PubMed ID: 12941576 [TBL] [Abstract][Full Text] [Related]
4. Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology. O'Brien JT; Holmes C; Jones M; Jones R; Livingston G; McKeith I; Mittler P; Passmore P; Ritchie C; Robinson L; Sampson EL; Taylor JP; Thomas A; Burns A J Psychopharmacol; 2017 Feb; 31(2):147-168. PubMed ID: 28103749 [TBL] [Abstract][Full Text] [Related]
5. Alternative drug therapies for dementia. Howland RH J Psychosoc Nurs Ment Health Serv; 2011 May; 49(5):17-20. PubMed ID: 21553703 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological treatments of behavioral and psychological symptoms of dementia in Alzheimer's disease: role of acetylcholinesterase inhibitors and memantine. Desmidt T; Hommet C; Camus V Geriatr Psychol Neuropsychiatr Vieil; 2016 Sep; 14(3):300-6. PubMed ID: 27651011 [TBL] [Abstract][Full Text] [Related]
8. Pharmacotherapeutic approaches to the treatment of Alzheimer's disease. Standridge JB Clin Ther; 2004 May; 26(5):615-30. PubMed ID: 15220008 [TBL] [Abstract][Full Text] [Related]
9. A review comparing the safety and tolerability of memantine with the acetylcholinesterase inhibitors. Jones RW Int J Geriatr Psychiatry; 2010 Jun; 25(6):547-53. PubMed ID: 20049770 [TBL] [Abstract][Full Text] [Related]
10. Management of Depression in Patients with Dementia: Is Pharmacological Treatment Justified? Ford AH; Almeida OP Drugs Aging; 2017 Feb; 34(2):89-95. PubMed ID: 28074409 [TBL] [Abstract][Full Text] [Related]
11. Outcomes of Alzheimer's disease therapy with acetylcholinesterase inhibitors and memantine. Zemek F; Drtinova L; Nepovimova E; Sepsova V; Korabecny J; Klimes J; Kuca K Expert Opin Drug Saf; 2014 Jun; 13(6):759-74. PubMed ID: 24845946 [TBL] [Abstract][Full Text] [Related]
12. Treatment strategies for the behavioral symptoms of Alzheimer's disease: focus on early pharmacologic intervention. Beier MT Pharmacotherapy; 2007 Mar; 27(3):399-411. PubMed ID: 17316151 [TBL] [Abstract][Full Text] [Related]
13. Combination therapy for early Alzheimer's disease: what are we waiting for? Doraiswamy PM; Steffens DC J Am Geriatr Soc; 1998 Oct; 46(10):1322-4. PubMed ID: 9777922 [TBL] [Abstract][Full Text] [Related]
14. Pharmacotherapy for Dementia: A Practical Approach to the Use of Cholinesterase Inhibitors and Memantine. Wong CW Drugs Aging; 2016 Jul; 33(7):451-60. PubMed ID: 27154396 [TBL] [Abstract][Full Text] [Related]
17. Choosing treatment for Alzheimer's patients and their caregivers. Schneider LS; Porsteinsson AP; Peskin ER; Pfeiffer EA Geriatrics; 2003 Aug; 58 Suppl 1():3-18, 23; quiz 19-22. PubMed ID: 12961833 [No Abstract] [Full Text] [Related]
18. A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer's disease. Di Santo SG; Prinelli F; Adorni F; Caltagirone C; Musicco M J Alzheimers Dis; 2013; 35(2):349-61. PubMed ID: 23411693 [TBL] [Abstract][Full Text] [Related]
19. [Pharmacological therapy in Alzheimer's disease. Current clinical practice in The Netherlands]. Schölzel-Dorenbos CJ; Tijdschr Gerontol Geriatr; 2005 Jul; 36(3):122-6. PubMed ID: 16078659 [TBL] [Abstract][Full Text] [Related]